Carvidon-OD Tablet MR
By Carvidon
Rx
15 Tablet in a Strip

Composition
Trimetazidine(60mg)

Manufacturer - Micro Labs Ltd
27, RACE COURSE ROAD, BANGALORE-560 001, INDIA

Expires on or after
April, 2026

liver
Limited information is currently available regarding the safety of using Carvidon-OD Tablet MR in patients with liver disease. It is strongly advised to consult your doctor before taking this medication if you have any liver-related issues. Your doctor will be able to provide guidance and determine the appropriate course of action based on your individual health needs.

kidney
Carvidon-OD Tablet MR should be used carefully in patients with kidney disease. Dosage may require adjustment, and consulting your doctor is important. It is not advised for use in patients with severe kidney disease.

alcohol
When using Carvidon-OD Tablet MR, be cautious as it can cause increased drowsiness when taken with alcohol.

driving
Carvidon-OD Tablet MR can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Information on the use of Carvidon-OD Tablet MR during pregnancy is unavailable. It is advisable to consult your doctor for guidance.

breastfeeding
It is better to consult your doctor before using Carvidon-OD Tablet MR during breastfeeding.
Habit Forming | No |
Chemical Class | Phenylmethylamines |
Therapeutic Class | CARDIAC |
Action Class | Fatty acid modulator & Sodium channel blocker |
₹384
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024